4//SEC Filing
OptimizeRx Corp 4
Accession 0001213900-17-006118
$OPRXCIK 0001448431operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:18 PM ET
Size
4.6 KB
Accession
0001213900-17-006118
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Harrell David
DirectorChairman of the Board10% Owner
Transactions
- Disposition to Issuer
Common Stock
2017-06-01$0.78/sh−500,000$390,000→ 2,090,750 total
Footnotes (1)
- [F1]The shares were repurchased by the Company pursuant to an agreement dated May 11, 2017, which is attached to the Company's Form 8-K and filed with the SEC on May 17, 2017.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001448431
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:18 PM ET
- Size
- 4.6 KB